by Steven Ertelt
April 10, 2007
West Monroe, NY (LifeNews.com) — Abortion advocates said this wasn’t supposed to happen once abortion was legalized. However, a New York woman is the latest to be charged by police with a self-abortion after she ingested several over-the-counter and prescription medications to kill her unborn child.
The unnamed woman is only the latest to be charged after police charged a woman in Massachusetts just weeks ago with producing a miscarriage.
Last month, police didn’t charge a woman in Georgia who performed a self abortion and stored two fetuses in her shed. And last year, a judge tossed charges against a Virginia woman after she shot herself in the stomach in a desperate bid to end her pregnancy.
In the New York case, police in Oswego arrested 24 year-old Katrina L. Pierce of West Monroe after she reportedly attempted to kill her unborn 13 week old unborn baby by ingesting the drugs.
Released on an appearance ticket, she is scheduled to answer the charges in court on April 19.
According to New York state law, someone can be guilty of a self-abortion in the second degree.
In the Massachusetts case, Amber Abreu, 18, used an anti-ulcer drug to cause an abortion and kill her unborn child even though its maker warns it shouldn’t be utilized for that purpose. She now regrets her decision.
"If I could turn back the clock, I would do things differently," Abreu told the Eagle Tribune newspaper in an interview late last month. "Those people who judge me don’t know what I’m feeling inside."
After using the drug, which failed to kill the child immediately, Abreu gave birth to a baby girl January 6 who weighed just 1.25 pounds.
Despite the delivery, baby Ashley Abreu was unable to be saved and she died four days later at a local Boston hospital.
As a result of her actions, Abreu was indicted by an Essex County Grand Jury on charges of illegally producing a miscarriage and prosecutors considered charged her with the murder of the baby. They’ve since dropped those charges.
Some abortion practitioners engage in what is known as "off-label" use because it has been found to be relatively effective in producing contractions. The maker of that drug, Searle, has issued warnings in both the United States and Australia that the misuse is dangerous for women.